Statistics for Immunic (id:8392 IMUX)
Valuation metrics
Market cap
96.38M
Enterprise value
36.41M
Trailing P/E (ttm)
-0.52
Forward P/E
-1.67
PEG ratio
-1.67
Price/Sales (ttm)
Price/Book (mrq)
2.34
Enterprise Value/Revenue
Enterprise Value/EBITDA
-0.38
Overview
Shares outstanding
90.08M
Float
52.16M
Shares short
4.50M
% Held by insiders
0.03%
% Held by institutions
0.65%
Average volume (10 days)
1.05M
Average volume (90 days)
Price summary
52-Week low
0.97
52-Week high
2.11
52-Week change
-6.36%
Beta
1.88
50-Day moving average
1.43
200-Day moving average
1.34
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
April 15th, 2019
Ex-dividend date
Last split factor
2:1
Last split date
April 15th, 2019
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-90.90%
Return on equity
-216.24%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-95,680,000.00
Net income to common (ttm)
-96,904,000.00
Diluted EPS (ttm)
-1.23
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
59.07M
Total cash per share (mrq)
0.66
Total debt (mrq)
899.00K
Total Debt/Equity (mrq)
2.18
Current ratio (mrq)
270.90%
Book value per share (mrq)
0.46
Cash flow
Cash flow statement
-75,830,000.00
Levered free cash flow (LFCF)
-45,125,248.00